The Contribution of Fluorine 18F-FDG PET/CT to Lung Cancer Diagnosis, Staging and Treatment Planning | Zendy

Emine Budak | Zendy; Gürsel Çok | Zendy; Ayşegül Akgün | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Contribution of Fluorine 18F-FDG PET/CT to Lung Cancer Diagnosis, Staging and Treatment Planning

Author(s) -

Emine Budak,

Gürsel Çok,

Ayşegül Akgün

Publication year - 2018

Publication title -

molecular imaging and radionuclide therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.292

H-Index - 7

eISSN - 2147-1959

pISSN - 2146-1414

DOI - 10.4274/mirt.53315

Subject(s) - medicine , lung cancer , malignancy , positron emission tomography , standardized uptake value , radiology , adenocarcinoma , nuclear medicine , cancer , lung , fluorodeoxyglucose , pet ct , oncology

Lung cancer is the most common cause of cancer-related death throughout the world, and the correct choice of treatment based on early diagnosis and staging increases the chance of survival. The present study aims to investigate the contribution of fluorine 18-fluorodeoxyglucose-positron emission tomography/computed tomography ( 18 F-FDG PET/CT) to the management of lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research